Global Friedreich Ataxia Drug Market Insights, Forecast to 2025

Publisher Name :
Date: 04-Mar-2019
No. of pages: 128
Inquire Before Buying

The global Friedreich Ataxia Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Friedreich Ataxia Drug market based on company, product type, end user and key regions.

This report studies the global market size of Friedreich Ataxia Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Friedreich Ataxia Drug in these regions.

This research report categorizes the global Friedreich Ataxia Drug market by top players/brands, region, type and end user. This report also studies the global Friedreich Ataxia Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Adverum Biotechnologies Inc

- BioMarin Pharmaceutical Inc.

- Biovista Inc.

- Cardero Therapeutics Inc

- Catabasis Pharmaceuticals, Inc.

- Forward Pharma A/S

- Ixchel Pharma LLC

- Pfizer Inc

- ProQR Therapeutics NV

- RaNA Therapeutics Inc

- Reata Pharmaceuticals Inc

- Retrotope Inc

- Shire Plc

- STATegics Inc

- Voyager Therapeutics Inc

Market size by Product

- ADVM-063

- AGIL-FA

- BHV-4157

- BVA-202

- Others

Market size by End User

- Clinic

- Hospital

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Friedreich Ataxia Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Friedreich Ataxia Drug market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Friedreich Ataxia Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Friedreich Ataxia Drug submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Friedreich Ataxia Drug are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Friedreich Ataxia Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Friedreich Ataxia Drug Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Friedreich Ataxia Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Friedreich Ataxia Drug Market Size Growth Rate by Product
1.4.2 ADVM-063
1.4.3 AGIL-FA
1.4.4 BHV-4157
1.4.5 BVA-202
1.4.6 Others
1.5 Market by End User
1.5.1 Global Friedreich Ataxia Drug Market Size Growth Rate by End User
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Friedreich Ataxia Drug Market Size
2.1.1 Global Friedreich Ataxia Drug Revenue 2014-2025
2.1.2 Global Friedreich Ataxia Drug Sales 2014-2025
2.2 Friedreich Ataxia Drug Growth Rate by Regions
2.2.1 Global Friedreich Ataxia Drug Sales by Regions
2.2.2 Global Friedreich Ataxia Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Friedreich Ataxia Drug Sales by Manufacturers
3.1.1 Friedreich Ataxia Drug Sales by Manufacturers
3.1.2 Friedreich Ataxia Drug Sales Market Share by Manufacturers
3.1.3 Global Friedreich Ataxia Drug Market Concentration Ratio (CR5 and HHI)
3.2 Friedreich Ataxia Drug Revenue by Manufacturers
3.2.1 Friedreich Ataxia Drug Revenue by Manufacturers (2014-2019)
3.2.2 Friedreich Ataxia Drug Revenue Share by Manufacturers (2014-2019)
3.3 Friedreich Ataxia Drug Price by Manufacturers
3.4 Friedreich Ataxia Drug Manufacturing Base Distribution, Product Types
3.4.1 Friedreich Ataxia Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Friedreich Ataxia Drug Product Type
3.4.3 Date of International Manufacturers Enter into Friedreich Ataxia Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Friedreich Ataxia Drug Sales by Product
4.2 Global Friedreich Ataxia Drug Revenue by Product
4.3 Friedreich Ataxia Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Friedreich Ataxia Drug Breakdown Data by End User
6 North America
6.1 North America Friedreich Ataxia Drug by Countries
6.1.1 North America Friedreich Ataxia Drug Sales by Countries
6.1.2 North America Friedreich Ataxia Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Friedreich Ataxia Drug by Product
6.3 North America Friedreich Ataxia Drug by End User
7 Europe
7.1 Europe Friedreich Ataxia Drug by Countries
7.1.1 Europe Friedreich Ataxia Drug Sales by Countries
7.1.2 Europe Friedreich Ataxia Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Friedreich Ataxia Drug by Product
7.3 Europe Friedreich Ataxia Drug by End User
8 Asia Pacific
8.1 Asia Pacific Friedreich Ataxia Drug by Countries
8.1.1 Asia Pacific Friedreich Ataxia Drug Sales by Countries
8.1.2 Asia Pacific Friedreich Ataxia Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Friedreich Ataxia Drug by Product
8.3 Asia Pacific Friedreich Ataxia Drug by End User
9 Central & South America
9.1 Central & South America Friedreich Ataxia Drug by Countries
9.1.1 Central & South America Friedreich Ataxia Drug Sales by Countries
9.1.2 Central & South America Friedreich Ataxia Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Friedreich Ataxia Drug by Product
9.3 Central & South America Friedreich Ataxia Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Friedreich Ataxia Drug by Countries
10.1.1 Middle East and Africa Friedreich Ataxia Drug Sales by Countries
10.1.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Friedreich Ataxia Drug by Product
10.3 Middle East and Africa Friedreich Ataxia Drug by End User
11 Company Profiles
11.1 Adverum Biotechnologies Inc
11.1.1 Adverum Biotechnologies Inc Company Details
11.1.2 Company Business Overview
11.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Products Offered
11.1.5 Adverum Biotechnologies Inc Recent Development
11.2 BioMarin Pharmaceutical Inc.
11.2.1 BioMarin Pharmaceutical Inc. Company Details
11.2.2 Company Business Overview
11.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Products Offered
11.2.5 BioMarin Pharmaceutical Inc. Recent Development
11.3 Biovista Inc.
11.3.1 Biovista Inc. Company Details
11.3.2 Company Business Overview
11.3.3 Biovista Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Biovista Inc. Friedreich Ataxia Drug Products Offered
11.3.5 Biovista Inc. Recent Development
11.4 Cardero Therapeutics Inc
11.4.1 Cardero Therapeutics Inc Company Details
11.4.2 Company Business Overview
11.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Products Offered
11.4.5 Cardero Therapeutics Inc Recent Development
11.5 Catabasis Pharmaceuticals, Inc.
11.5.1 Catabasis Pharmaceuticals, Inc. Company Details
11.5.2 Company Business Overview
11.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Products Offered
11.5.5 Catabasis Pharmaceuticals, Inc. Recent Development
11.6 Forward Pharma A/S
11.6.1 Forward Pharma A/S Company Details
11.6.2 Company Business Overview
11.6.3 Forward Pharma A/S Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Forward Pharma A/S Friedreich Ataxia Drug Products Offered
11.6.5 Forward Pharma A/S Recent Development
11.7 Ixchel Pharma LLC
11.7.1 Ixchel Pharma LLC Company Details
11.7.2 Company Business Overview
11.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Ixchel Pharma LLC Friedreich Ataxia Drug Products Offered
11.7.5 Ixchel Pharma LLC Recent Development
11.8 Pfizer Inc
11.8.1 Pfizer Inc Company Details
11.8.2 Company Business Overview
11.8.3 Pfizer Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Pfizer Inc Friedreich Ataxia Drug Products Offered
11.8.5 Pfizer Inc Recent Development
11.9 ProQR Therapeutics NV
11.9.1 ProQR Therapeutics NV Company Details
11.9.2 Company Business Overview
11.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Products Offered
11.9.5 ProQR Therapeutics NV Recent Development
11.10 RaNA Therapeutics Inc
11.10.1 RaNA Therapeutics Inc Company Details
11.10.2 Company Business Overview
11.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Products Offered
11.10.5 RaNA Therapeutics Inc Recent Development
11.11 Reata Pharmaceuticals Inc
11.12 Retrotope Inc
11.13 Shire Plc
11.14 STATegics Inc
11.15 Voyager Therapeutics Inc
12 Future Forecast
12.1 Friedreich Ataxia Drug Market Forecast by Regions
12.1.1 Global Friedreich Ataxia Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Friedreich Ataxia Drug Revenue Forecast by Regions 2019-2025
12.2 Friedreich Ataxia Drug Market Forecast by Product
12.2.1 Global Friedreich Ataxia Drug Sales Forecast by Product 2019-2025
12.2.2 Global Friedreich Ataxia Drug Revenue Forecast by Product 2019-2025
12.3 Friedreich Ataxia Drug Market Forecast by End User
12.4 North America Friedreich Ataxia Drug Forecast
12.5 Europe Friedreich Ataxia Drug Forecast
12.6 Asia Pacific Friedreich Ataxia Drug Forecast
12.7 Central & South America Friedreich Ataxia Drug Forecast
12.8 Middle East and Africa Friedreich Ataxia Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Friedreich Ataxia Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Friedreich Ataxia Drug Product Picture
Table Friedreich Ataxia Drug Market Segments
Table Key Manufacturers Friedreich Ataxia Drug Covered
Table Global Friedreich Ataxia Drug Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)
Figure Global Friedreich Ataxia Drug Sales Market Share by Product 2014-2025
Figure ADVM-063 Product Picture
Table Major Manufacturers of ADVM-063
Figure AGIL-FA Product Picture
Table Major Manufacturers of AGIL-FA
Figure BHV-4157 Product Picture
Table Major Manufacturers of BHV-4157
Figure BVA-202 Product Picture
Table Major Manufacturers of BVA-202
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Friedreich Ataxia Drug Market Size Growth Rate by End User 2019-2025 (K Pcs)
Figure Clinic
Figure Hospital
Figure Others
Figure Friedreich Ataxia Drug Report Years Considered
Figure Global Friedreich Ataxia Drug Market Size 2014-2025 (Million US$)
Figure Global Friedreich Ataxia Drug Sales 2014-2025 (K Pcs)
Table Global Friedreich Ataxia Drug Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Friedreich Ataxia Drug Sales by Regions 2014-2019 (K Pcs)
Table Global Friedreich Ataxia Drug Sales Market Share by Regions 2014-2019
Figure Global Friedreich Ataxia Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Friedreich Ataxia Drug Sales Market Share by Regions
Table Global Friedreich Ataxia Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Friedreich Ataxia Drug Revenue Market Share by Regions 2014-2019
Figure Global Friedreich Ataxia Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Friedreich Ataxia Drug Revenue Market Share by Regions
Table Global Friedreich Ataxia Drug Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Friedreich Ataxia Drug Sales Share by Manufacturers (2014-2019)
Figure Global Friedreich Ataxia Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Friedreich Ataxia Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Friedreich Ataxia Drug Revenue Share by Manufacturers (2014-2019)
Figure Friedreich Ataxia Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Friedreich Ataxia Drug Price (2014-2019) (USD/Pcs)
Table Friedreich Ataxia Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Friedreich Ataxia Drug Product Type
Table Date of International Manufacturers Enter into Friedreich Ataxia Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Friedreich Ataxia Drug Sales by Product (2014-2019) (K Pcs)
Table Global Friedreich Ataxia Drug Sales Share by Product (2014-2019)
Figure Global Friedreich Ataxia Drug Sales Market Share by Product (2014-2019)
Figure Global Friedreich Ataxia Drug Sales Market Share by Product in 2018
Table Global Friedreich Ataxia Drug Revenue by Product (2014-2019) (Million US$)
Table Global Friedreich Ataxia Drug Revenue Share by Product (2014-2019)
Figure Global Friedreich Ataxia Drug Revenue Market Share by Product (2014-2019)
Figure Global Friedreich Ataxia Drug Revenue Market Share by Product in 2018
Table Friedreich Ataxia Drug Price by Product 2014-2019 (USD/Pcs)
Table Global Friedreich Ataxia Drug Sales by End User (2014-2019) (K Pcs)
Table Global Friedreich Ataxia Drug Sales Share by End User (2014-2019)
Figure Global Sales Friedreich Ataxia Drug Market Share by End User (2014-2019)
Figure Global Sales Friedreich Ataxia Drug Market Share by End User in 2018
Figure North America Friedreich Ataxia Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Friedreich Ataxia Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Friedreich Ataxia Drug Sales by Countries (2014-2019) (K Pcs)
Table North America Friedreich Ataxia Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Friedreich Ataxia Drug Sales Market Share by Countries
Table North America Friedreich Ataxia Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Friedreich Ataxia Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Friedreich Ataxia Drug Revenue Market Share by Countries
Figure United States Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Friedreich Ataxia Drug Sales by Product (2014-2019) (K Pcs)
Table North America Friedreich Ataxia Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Friedreich Ataxia Drug Market Share by Product
Table North America Friedreich Ataxia Drug Sales by End User (2014-2019) (K Pcs)
Table North America Friedreich Ataxia Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Friedreich Ataxia Drug Market Share by End User
Figure Europe Friedreich Ataxia Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Friedreich Ataxia Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Friedreich Ataxia Drug Sales by Countries (2014-2019) (K Pcs)
Table Europe Friedreich Ataxia Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Friedreich Ataxia Drug Sales Market Share by Countries
Table Europe Friedreich Ataxia Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Friedreich Ataxia Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Friedreich Ataxia Drug Revenue Market Share by Countries
Figure Germany Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure France Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Friedreich Ataxia Drug Sales by Product (2014-2019) (K Pcs)
Table Europe Friedreich Ataxia Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Friedreich Ataxia Drug Market Share by Product
Table Europe Friedreich Ataxia Drug Sales by End User (2014-2019) (K Pcs)
Table Europe Friedreich Ataxia Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Friedreich Ataxia Drug Market Share by End User
Figure Asia Pacific Friedreich Ataxia Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Friedreich Ataxia Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Friedreich Ataxia Drug Sales by Countries (2014-2019) (K Pcs)
Table Asia Pacific Friedreich Ataxia Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Friedreich Ataxia Drug Sales Market Share by Countries
Table Asia Pacific Friedreich Ataxia Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Friedreich Ataxia Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Friedreich Ataxia Drug Revenue Market Share by Countries
Figure China Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure China Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure India Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Friedreich Ataxia Drug Sales by Product (2014-2019) (K Pcs)
Table Asia Pacific Friedreich Ataxia Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Friedreich Ataxia Drug Market Share by Product
Table Asia Pacific Friedreich Ataxia Drug Sales by End User (2014-2019) (K Pcs)
Table Asia Pacific Friedreich Ataxia Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Friedreich Ataxia Drug Market Share by End User
Figure Central & South America Friedreich Ataxia Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Friedreich Ataxia Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Friedreich Ataxia Drug Sales by Countries (2014-2019) (K Pcs)
Table Central & South America Friedreich Ataxia Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Friedreich Ataxia Drug Sales Market Share by Countries
Table Central & South America Friedreich Ataxia Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Friedreich Ataxia Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Friedreich Ataxia Drug Revenue Market Share by Countries
Figure Brazil Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Friedreich Ataxia Drug Sales by Product (2014-2019) (K Pcs)
Table Central & South America Friedreich Ataxia Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Friedreich Ataxia Drug Market Share by Product
Table Central & South America Friedreich Ataxia Drug Sales by End User (2014-2019) (K Pcs)
Table Central & South America Friedreich Ataxia Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Friedreich Ataxia Drug Market Share by End User
Figure Middle East and Africa Friedreich Ataxia Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Friedreich Ataxia Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Friedreich Ataxia Drug Sales by Countries (2014-2019) (K Pcs)
Table Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Countries
Table Middle East and Africa Friedreich Ataxia Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Friedreich Ataxia Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Friedreich Ataxia Drug Revenue Market Share by Countries
Figure GCC Countries Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Friedreich Ataxia Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Friedreich Ataxia Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Friedreich Ataxia Drug Sales by Product (2014-2019) (K Pcs)
Table Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Friedreich Ataxia Drug Market Share by Product
Table Middle East and Africa Friedreich Ataxia Drug Sales by End User (2014-2019) (K Pcs)
Table Middle East and Africa Friedreich Ataxia Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Friedreich Ataxia Drug Market Share by End User
Table Adverum Biotechnologies Inc Company Details
Table Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Adverum Biotechnologies Inc Recent Development
Table BioMarin Pharmaceutical Inc. Company Details
Table BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioMarin Pharmaceutical Inc. Recent Development
Table Biovista Inc. Company Details
Table Biovista Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biovista Inc. Recent Development
Table Cardero Therapeutics Inc Company Details
Table Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cardero Therapeutics Inc Recent Development
Table Catabasis Pharmaceuticals, Inc. Company Details
Table Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Catabasis Pharmaceuticals, Inc. Recent Development
Table Forward Pharma A/S Company Details
Table Forward Pharma A/S Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Forward Pharma A/S Recent Development
Table Ixchel Pharma LLC Company Details
Table Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ixchel Pharma LLC Recent Development
Table Pfizer Inc Company Details
Table Pfizer Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Inc Recent Development
Table ProQR Therapeutics NV Company Details
Table ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table ProQR Therapeutics NV Recent Development
Table RaNA Therapeutics Inc Company Details
Table RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table RaNA Therapeutics Inc Recent Development
Table Reata Pharmaceuticals Inc Company Details
Table Retrotope Inc Company Details
Table Shire Plc Company Details
Table STATegics Inc Company Details
Table Voyager Therapeutics Inc Company Details
Table Global Friedreich Ataxia Drug Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Friedreich Ataxia Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Friedreich Ataxia Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Friedreich Ataxia Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Friedreich Ataxia Drug Sales Forecast by Product 2019-2025 (K Pcs)
Table Global Friedreich Ataxia Drug Sales Market Share Forecast by Product 2019-2025
Table Global Friedreich Ataxia Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Friedreich Ataxia Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Friedreich Ataxia Drug Sales Forecast by End User 2019-2025 (K Pcs)
Table Global Friedreich Ataxia Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Friedreich Ataxia Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Friedreich Ataxia Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Friedreich Ataxia Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Friedreich Ataxia Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Friedreich Ataxia Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Friedreich Ataxia Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Friedreich Ataxia Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Friedreich Ataxia Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Friedreich Ataxia Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Friedreich Ataxia Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Friedreich Ataxia Drug Value Chain
Table Friedreich Ataxia Drug Customers List
Table Friedreich Ataxia Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Pancreatic and Bile Duct Cancer Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 22-Jul-2019        Price: US 3480 Onwards        Pages: 135
    It is a drug for treating pancreatic cancer with bile duct cancer. Scope of the Report: Pancreatic cancer is a disease in which malignant (cancer) cells are found in pancreatic tissue. The pancreas is a large gland located in the abdominal cavity and is responsible for the secretion of digestive juice and insulin. Symptoms and signs include upper abdominal pain, yellowish skin and white eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Susce......
  • Global Rheumatic Disorders Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 22-Jul-2019        Price: US 3480 Onwards        Pages: 107
    Treatment of drugs for regulating rheumatic diseases Scope of the Report: Rheumatic diseases are a series of diseases characterized by chronic pain. Some of the most common diseases are osteoarthritis (OA) and rheumatoid arthritis (RA), and most rheumatic diseases use basically universal pain control drugs. Treatment is ongoing and there are no treatments for any of the key indications, so there is a need to develop better disease modulating drugs. The global Rheumat......
  • Global Pet Veterinary Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Jul-2019        Price: US 3480 Onwards        Pages: 102
    Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets. Scope of the Report: The global pet veterinary drug market is divided into drugs and biological agents and vaccines according to drugs. According to the ingredients, it is divided into anti-infectives, anti-inflammatory drugs, parasiticides, analgesics and sedatives. Due to the significant growth of the global healthcare industry, global demand for pet ......
  • Global Amyloid Peptides Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Jul-2019        Price: US 3480 Onwards        Pages: 105
    Scope of the Report: The worldwide market for Amyloid Peptides is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Amyloid Peptides in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and app......
  • Global Xylitol in Pharmaceutical Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Jul-2019        Price: US 3480 Onwards        Pages: 107
    Xylitol is a derivative of xylose, Chemical formula: CH2OH (CHOH) 3CH2OH. Xylitol is a sugar alcohol, a low-calorie carbohydrate made from birch bark, corn cobs, fibrous vegetables and fruit. Scope of the Report: The worldwide market for Xylitol in Pharmaceutical is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses......
  • Global Tamiflu (Oseltamivir Phosphate) Market Insights, Forecast to 2025
    Published: 19-Jul-2019        Price: US 3900 Onwards        Pages: 112
    Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B (flu). The global Tamiflu (Oseltamivir Phosphate) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tamiflu (Oseltamivir Phosphate) market based on company, product type, end user and key regions.......
  • Global Dental Silica Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 19-Jul-2019        Price: US 2900 Onwards        Pages: 193
    The Dental Silica market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Dental Silica. Global Dental Silica industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, and g......
  • Global Eye Allergy Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jul-2019        Price: US 3480 Onwards        Pages: 118
    All types of eye allergies are associated with chronic symptoms such as ocular itching inflammation redness and watery eyes, which are persistently disturbing, having an adverse effect on patients' life. Scope of the Report: The worldwide market for Eye Allergy Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focu......
  • Global Radiodermatitis Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jul-2019        Price: US 3480 Onwards        Pages: 119
    Radiodermatitis is the integumentary system's response to exposure to ionizing radiation. Scope of the Report: The worldwide market for Radiodermatitis Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Radiodermatitis Treatment in global market, especially in North America, Europe and Asia-Pacific, Sou......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs